Vasotec: Advanced Blood Pressure Control for Heart Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.70 | $42.14 (0%) | 🛒 Add to cart |
| 90 | $0.62 | $63.21 $55.90 (12%) | 🛒 Add to cart |
| 120 | $0.58 | $84.28 $69.66 (17%) | 🛒 Add to cart |
| 180 | $0.54 | $126.42 $97.18 (23%) | 🛒 Add to cart |
| 270 | $0.51 | $189.63 $138.46 (27%) | 🛒 Add to cart |
| 360 | $0.49
Best per pill | $252.84 $178.02 (30%) | 🛒 Add to cart |
Vasotec (enalapril maleate) is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension, heart failure, and asymptomatic left ventricular dysfunction. This medication works by relaxing blood vessels, allowing blood to flow more smoothly and reducing the heart’s workload. Clinical evidence supports its efficacy in improving survival rates in heart failure patients and slowing the progression of kidney disease in hypertensive diabetics. Proper usage under medical supervision makes Vasotec a cornerstone therapy in cardiovascular protection strategies.
Features
- Active ingredient: enalapril maleate
- Available in 2.5 mg, 5 mg, 10 mg, and 20 mg tablet strengths
- FDA-approved for hypertension, heart failure, and asymptomatic left ventricular dysfunction
- Once or twice-daily dosing regimen
- Standard tablet formulation for oral administration
- Prescription-only medication requiring regular monitoring
Benefits
- Effectively lowers high blood pressure, reducing stroke and heart attack risk
- Improves survival rates in patients with congestive heart failure
- Slows progression of kidney damage in hypertensive patients with diabetes
- Reduces symptoms of heart failure such as shortness of breath and fatigue
- Provides 24-hour blood pressure control with consistent dosing
- May be used in combination with other antihypertensive agents for enhanced effect
Common use
Vasotec is primarily prescribed for the management of essential hypertension, either as monotherapy or in combination with thiazide diuretics. It is also indicated for the treatment of symptomatic heart failure, often used alongside diuretics and digitalis. Additionally, physicians may prescribe Vasotec for asymptomatic left ventricular dysfunction (ejection fraction ≤35%) to prevent overt heart failure development. The medication has shown particular benefit in diabetic patients with hypertension, where it helps preserve renal function. Off-label uses may include management of diabetic nephropathy and certain types of chronic kidney disease.
Dosage and direction
Hypertension: The recommended initial dose is 5 mg once daily for patients not on diuretics. Dosage may be increased to 10-40 mg daily administered as a single dose or in two divided doses. The usual dosage range is 10-40 mg per day.
Heart Failure: Therapy should be initiated under close medical supervision at 2.5 mg once daily. The recommended dosage range is 2.5-20 mg given twice daily, with target maintenance dose of 10 mg twice daily.
Asymptomatic Left Ventricular Dysfunction: The recommended initial dose is 2.5 mg twice daily, titrated as tolerated to 10 mg twice daily.
Dosage adjustment is required for patients with renal impairment: For creatinine clearance <30 mL/min/1.73m², the initial dose is 2.5 mg daily. Tablets should be swallowed whole with water, with or without food, at approximately the same time each day.
Precautions
Patients should be monitored for hypotension, especially during initial dosing and dose escalation. Renal function and serum potassium should be assessed before and during treatment. Angioedema may occur at any time during therapy, requiring immediate medical attention. Neutropenia/agranulocytosis has been reported with ACE inhibitors; white blood cell counts should be monitored in patients with collagen vascular disease or renal impairment. Use with caution in patients with aortic stenosis or hypertrophic cardiomyopathy. Surgery/anesthesia may require dosage adjustment. Patients should report any signs of infection (sore throat, fever) promptly. Caution is advised when operating machinery or driving until the patient’s response to therapy is established.
Contraindications
Vasotec is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment. It should not be used in patients with hereditary or idiopathic angioedema. Concomitant use with aliskiren-containing products is contraindicated in patients with diabetes. The medication is contraindicated in combination with neprilysin inhibitors (e.g., sacubitril) due to increased risk of angioedema. Pregnancy constitutes an absolute contraindication due to potential fetal harm, particularly during the second and third trimesters. Hypersensitivity to any component of this product or other ACE inhibitors prohibits its use.
Possible side effect
Common side effects (≥1%) include dizziness (4.3%), headache (2.2%), fatigue (2.0%), cough (1.3%), and nausea (1.1%). Less frequent adverse reactions may include orthostatic hypotension, rash, impaired renal function, hyperkalemia, and taste disturbance. Serious but rare side effects include angioedema (0.2%), neutropenia/agranulocytosis, hepatic failure, and pancreatitis. Approximately 2.5% of patients discontinue therapy due to side effects, most commonly cough (0.7%) and dizziness (0.5%). Most side effects are mild and transient, often resolving with continued therapy or dosage adjustment.
Drug interaction
Potassium supplements/potassium-sparing diuretics: Increased risk of hyperkalemia Lithium: Increased lithium levels and toxicity risk Diuretics: Enhanced hypotensive effect, especially with first dose NSAIDs: May reduce antihypertensive effect and worsen renal function Gold injections: Nitritoid reactions reported with sodium aurothiomalate Antidiabetic agents: Enhanced hypoglycemic effect possible Sympathomimetics: May reduce antihypertensive effect MTOR inhibitors: Increased risk for angioedema Aliskiren: Contraindicated in diabetic patients due to renal impairment risk
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should never double the dose to make up for a missed one. Consistency in dosing is important for maintaining stable blood pressure control. If multiple doses are missed, patients should contact their healthcare provider for guidance on resuming therapy, as dosage adjustment may be necessary.
Overdose
Vasotec overdose may manifest as severe hypotension, which can progress to shock. Bradycardia, electrolyte disturbances, and renal failure may occur. Laboratory findings may include hyperkalemia and hyponatremia. Management involves supportive measures including volume expansion with normal saline to treat hypotension. Hemodialysis may be effective in removing enalapril and enalaprilat, with clearance rates of 62 mL/min for enalaprilat. Atropine may be used for bradycardia. Patients should be monitored for at least 24 hours as hypotensive effects may be prolonged. Symptomatic treatment should be provided based on clinical presentation.
Storage
Store Vasotec tablets at controlled room temperature (20-25°C or 68-77°F) with excursions permitted between 15-30°C (59-86°F). Keep in the original container with the lid tightly closed to protect from moisture and light. Do not store in bathroom cabinets where humidity levels fluctuate. Keep out of reach of children and pets. Do not use tablets that show signs of discoloration, cracking, or other physical deterioration. Properly discard any expired medication according to local regulations, preferably through medication take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Vasotec is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary, and patients should follow their physician’s specific instructions. The complete prescribing information should be consulted before initiating therapy. Never adjust dosage or discontinue medication without medical consultation. Report any adverse effects to your healthcare provider promptly.
Reviews
Clinical studies demonstrate Vasotec’s efficacy with 60-70% of hypertensive patients achieving blood pressure control (<90 mmHg diastolic). In heart failure trials, Vasotec reduced mortality by 16% compared to placebo over follow-up periods of up to 4 years. Patient satisfaction surveys indicate good tolerability, though cough remains a notable side effect in approximately 10% of users. Long-term studies show sustained efficacy with maintenance of renal protective effects in diabetic patients over 5-year periods. Real-world evidence supports the cardiovascular benefits observed in clinical trials, with particular effectiveness in elderly hypertensive patients.